Avantor Inc (AVTR)
20.86
-0.29
(-1.37%)
USD |
NYSE |
Nov 15, 11:23
Avantor Cash from Financing (Quarterly): -198.60M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -198.60M |
June 30, 2024 | -197.10M |
March 31, 2024 | -130.20M |
December 31, 2023 | -184.10M |
September 30, 2023 | -188.40M |
June 30, 2023 | -196.20M |
March 31, 2023 | -275.00M |
December 31, 2022 | -81.60M |
September 30, 2022 | -219.40M |
June 30, 2022 | -220.50M |
March 31, 2022 | -127.20M |
December 31, 2021 | 1.461B |
September 30, 2021 | 980.40M |
June 30, 2021 | 998.80M |
Date | Value |
---|---|
March 31, 2021 | -221.00M |
December 31, 2020 | -380.40M |
September 30, 2020 | -316.10M |
June 30, 2020 | -13.30M |
March 31, 2020 | -73.10M |
December 31, 2019 | -67.40M |
September 30, 2019 | -172.60M |
June 30, 2019 | 38.30M |
March 31, 2019 | -106.10M |
December 31, 2018 | -54.40M |
September 30, 2018 | -66.20M |
June 30, 2018 | 28.10M |
March 31, 2018 | -77.80M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-380.40M
Minimum
Dec 2020
1.461B
Maximum
Dec 2021
17.53M
Average
-186.25M
Median
Cash from Financing (Quarterly) Benchmarks
Revvity Inc | -873.74M |
Bruker Corp | -2.70M |
Azenta Inc | -224.44M |
Harvard Bioscience Inc | 2.104M |
Bionano Genomics Inc | -1.978M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 244.80M |
Cash from Investing (Quarterly) | -40.50M |
Free Cash Flow | 747.20M |
Free Cash Flow Per Share (Quarterly) | 0.2987 |
Free Cash Flow to Equity (Quarterly) | 397.90M |
Free Cash Flow to Firm (Quarterly) | 241.78M |
Free Cash Flow Yield | 5.26% |